// App-Quantinova.ai

2346 : Intratumoral administration of OncoVEXmGM-CSF results in local innate immune alterations and induces systemic anti-tumor effects in syngeneic mouse tumor models

Researchers

Presenter

  • Keegan Cooke

Principal Investigators

  • Karen Fitzgerald

  • Becky Yang

  • Juan Estrada

  • Brian Belmontes

  • Pedro Beltran

  • Achim K. Moesta

Medical Centers

  • Amgen Inc, Thousand Oaks, CA

  • Amgen Inc, South San Francisco, CA

Locations

  • United States

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Herpes simplex virus infection

  • Solid malignancies

Biomarkers

  • Granulocyte-macrophage-colony stimulating factor

Drug/Treatment

  • Imlygic

  • GM-CSF

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved